Cleveland Diagnostics
Cleveland, United States · Biotechnology, Financial Services, Health Care · 95 employees
Cleveland Diagnostics is a precision oncology company focused on changing the shape of cancer detection. The company has unlocked the diagnostic power of protein structure with its revolutionary IsoClear™ platform that enables novel diagnostics based on a cancer-specific, protein structure-based assessment using easy to execute tests within the clinical lab setting.
Funding history
- Funding Round — $14.4M — Oct 2025
- Funding Round — $56.5M — Jan 2024
- Funding Round — $75.0M — Jan 2024
- Funding Round — Undisclosed — Dec 2017
- Funding Round — $440K — Nov 2016
Recent signals
- Jan 26, 2026: Cleveland Diagnostics Appoints Michael Iskra as Chief Executive Officer
- Oct 20, 2025: Raised $14.4M
- Jan 31, 2024: Raised $56.5M
- Jan 17, 2024: Raised $75.0M
- Dec 13, 2017: Raised Undisclosed
- Nov 23, 2016: Raised $440K
See plans & pricing → Track Cleveland Diagnostics’s funding, hiring, and signals — with verified contacts — on Fundz.